Insuline Medical (Israel) Today
| INSL Stock | ILS 230.00 20.00 9.52% |
Performance0 of 100
| Odds Of DistressLess than 39
|
Insuline Medical is trading at 230.00 as of the 27th of November 2024, a 9.52 percent increase since the beginning of the trading day. The stock's open price was 210.0. Insuline Medical has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Insuline Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of May 2023 and ending today, the 27th of November 2024. Click here to learn more.
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel. Insuline Medical is traded on Tel Aviv Stock Exchange in Israel. More on Insuline Medical
Moving together with Insuline Stock
Moving against Insuline Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Insuline Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Insuline Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Insuline Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Medical Devices, Healthcare (View all Sectors) |
Insuline Medical (INSL) is traded on Tel Aviv Stock Exchange in Israel and employs 26 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 36.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Insuline Medical's market, we take the total number of its shares issued and multiply it by Insuline Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Insuline Medical operates under Healthcare sector and is part of Medical Devices industry.
Insuline Medical has accumulated about 1.15 M in cash with (7.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86.
Check Insuline Medical Probability Of Bankruptcy
Insuline Medical Risk Profiles
Although Insuline Medical's alpha and beta are two of the key measurements used to evaluate Insuline Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.65 | |||
| Standard Deviation | 5.22 | |||
| Variance | 27.29 | |||
| Risk Adjusted Performance | (0.02) |
Insuline Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Insuline Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Other Information on Investing in Insuline Stock
Insuline Medical financial ratios help investors to determine whether Insuline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Insuline with respect to the benefits of owning Insuline Medical security.